Selection of Optimal First-Line and Maintenance Therapies in Advanced Ovarian Cancer
Because randomized trial data has shown that many of the options for primary chemotherapy in patients with advanced ovarian cancer have similar outcomes, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Ovarian Cancer includes a large list of regimens – including in
Category
  • Ovarian Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Insights - Rectal Cancer, Version 6.2020
The NCCN Guidelines for Rectal Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with rectal cancer. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines.
Category
  • Rectal Cancer
Format
  • Monograph/Journal Supplement
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Optimizing the Management of Endometrial Cancer
The introduction of new methods for classifying endometrial cancers and assessing risk can create a challenging landscape for clinicians to navigate when evaluating patients and determining appropriate treatment. Education is needed to help clinicians apply updates to the NCCN Guidelines in their practice in order to promote optimal care of patients with endometrial cancer.
Category
  • Endometrial Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Insights - Survivorship, Version 2.2020
The NCCN Guidelines for Survivorship provide screening, evaluation, and treatment recommendations for consequences of adult-onset cancer and its treatment, with the goal of helping healthcare professionals who work with survivors, including those in primary care.
Category
  • Survivorship
Format
  • Monograph/Journal Supplement
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: New Targets in Breast Cancer Therapy
Triple-negative breast cancer continues to be labeled with a poor prognosis secondary to the fact that it tends to be more aggressive and poses a greater risk of recurrence. Because it lacks the receptors that many drugs have been designed to target, the standard of practices remains chemotherapy. Therefore, research has been focused on trying to identify other therapeutic targets for which we already have agents or are currently developing agents.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Breast Cancer
Staying up-to-date with the available treatment options is important for health care professionals to integrate new evidence-based data into their clinical practice, and being familiar with the toxicity profile is important to optimize patient outcomes.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Prostate Cancer
Clinicians need up-to-date information about when and how to use molecular assays to inform individual patient risk; the side effects of ADT and management options for these side effects; and the results of recent clinical trials in the non-metastatic CRPC setting, so that patients can receive optimal care and delay the onset of metastases as long as possible.
Category
  • Prostate Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
BCOP Test - Emerging Strategies for Pediatric Acute Lymphoblastic Leukemia Management
To be eligible to take the BCOP test, you must first complete all credit requirements for the educational activity. The test is available for an additional fee of $49. Each activity is this series is worth 1 hour of BCOP credit.
Category
Format
Credits
BCOP Test - Advances in Targeted Therapy and Immunotherapy for the Treatment of Kidney Cancer
To be eligible to take the BCOP test, you must first complete all credit requirements for the educational activity. The test is available for an additional fee of $49. Each activity is this series is worth 1 hour of BCOP credit.
Category
Format
Credits
BCOP Test - Current Therapy Options for Graft-Versus-Host Disease
To be eligible to take the BCOP test, you must first complete all credit requirements for the educational activity. The test is available for an additional fee of $49. Each activity is this series is worth 1 hour of BCOP credit.
Category
Format
Credits

Pages